IPO-bound Glenmark Life Sciences to focus on complex bulk drugs, contract business to drive growth – Moneycontrol.com
Representative image Glenmark Life Sciences, whose initial public offer is set to open on July 27, said the company is focused on scaling up its complex active pharmaceutical ingredients (API) port…
